The Enterprise Value as of December 2025 (TTM) for Xvivo Perfusion AB (publ) (XVIPF) is 5.76B

According to Xvivo Perfusion AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 5.76B. This represents a change of -38.75% compared to the average of 9.40B of the last 4 quarters.

Xvivo Perfusion AB (publ) (XVIPF) Historical Enterprise Value (quarterly & annually)

How has XVIPF Enterprise Value performed in the past?

The mean historical Enterprise Value of Xvivo Perfusion AB (publ) over the last ten years is 5.84B. The current 5.76B Enterprise Value has changed 9.76% with respect to the historical average. Over the past ten years (40 quarters), XVIPF's Enterprise Value was at its highest in in the September 2024 quarter at 15.67B. The Enterprise Value was at its lowest in in the March 2016 quarter at 1.04B.

Xvivo Perfusion AB (publ) (XVIPF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Xvivo Perfusion AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Xvivo Perfusion AB (publ) (XVIPF) Average Enterprise Value

How has XVIPF Enterprise Value performed in the past?

The current Enterprise Value of Xvivo Perfusion AB (publ) (XVIPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Xvivo Perfusion AB (publ) (XVIPF) Enterprise Value vs. Peers

How is XVIPF’s Enterprise Value compared to its peers?

Xvivo Perfusion AB (publ)’s Enterprise Value is greater than PolyNovo Limited (816.07M), greater than 4DMedical Limited (977.93M), greater than CellaVision AB (publ) (3.59B), greater than Lattice Biologics Ltd. (3.09M), less than Swedencare AB (publ) (7.44B), greater than Viva Biotech Holdings (4.12B), greater than Avon Technologies Plc (771.36M), less than Beijing Tong Ren Tang Chinese Medicine Company Limited (5.94B), less than Nxera Pharma Co., Ltd. (107.56B), greater than Avisa Diagnostics Inc. (132.65K),

Build a custom stock screener for Xvivo Perfusion AB (publ) (XVIPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xvivo Perfusion AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xvivo Perfusion AB (publ) (XVIPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xvivo Perfusion AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.